Literature DB >> 197445

Neuroleptics reduce spinal fluid cyclic AMP in schizophrenic patient.

J Biederman, R Rimon, R Ebstein, J Zohar, R Belmaker.   

Abstract

Cyclic AMP in the cerebrospinal fluid (CSF) was determined in a group of 10 schizophrenic patients before neuroleptic drug treatment and after a mean of 8 week's antipsychotic drug therapy. For 8 patients with marked to moderate treatment response a significant (p less than 0.01) decline in CSF cyclic AMP was observed. This result is consistent with the theory that blockade of postsynaptic dopamine receptors is a major mechanism of the antipsychotic action of neuroleptic drugs.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 197445     DOI: 10.1159/000117563

Source DB:  PubMed          Journal:  Neuropsychobiology        ISSN: 0302-282X            Impact factor:   2.328


  6 in total

1.  Cerebrospinal fluid cyclic AMP and acid monoamine metabolites following probenecid: studies in psychiatric patients.

Authors:  M B Bowers; R E Study
Journal:  Psychopharmacology (Berl)       Date:  1979-03-29       Impact factor: 4.530

2.  The effect of L-dopa and propranolol on human CSF cyclic nucleotides.

Authors:  R H Belmaker; R P Ebstein; J Biederman; R Stern; M Berman; H M van Praag
Journal:  Psychopharmacology (Berl)       Date:  1978-07-19       Impact factor: 4.530

3.  Plasma cyclic AMP and cyclic GMP in childhood-onset psychoses.

Authors:  M Goldberg; J Hattab; D Meir; R P Ebstein; R H Belmaker
Journal:  J Autism Dev Disord       Date:  1984-06

4.  Central levels of noradrenaline, 3-methoxy-4-hydroxyphenylethyleneglycol and cyclic AMP in the rat after activation of locus coeruleus neurons: influence of single and repeated neuroleptic treatment.

Authors:  J P Adèr; J B Sebens; J Korf
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

5.  Cyclic GMP in the CSF of patients with schizophrenia before and after neuroleptic treatment.

Authors:  R P Ebstein; J Biederman; R Rimon; J Zohar; R H Belmaker
Journal:  Psychopharmacology (Berl)       Date:  1976-12-21       Impact factor: 4.530

6.  Tardive dyskinesia: a clinical test of the supersensitivity hypothesis.

Authors:  M B Bowers; D Moore; D Tarsy
Journal:  Psychopharmacology (Berl)       Date:  1979-03-22       Impact factor: 4.530

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.